Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Exosomes Diagnostic and Therapeutics Market: Surging Global Cancer Incidents and Demand for Advanced Diagnostic Technology Is Accelerating Growth - Future Market Insights, Inc.

This image opens in the lightbox

News provided by

Future Market Insights

14 Jul, 2022, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

Trends, opportunities and forecast in exosomes diagnostic and therapeutics market to 2028 by product (instruments, reagents, and software), application (diagnostics and therapeutics), end user (cancer institutes, hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)

NEWARK, Del., July 14, 2022 /PRNewswire/ -- According to the detailed analytical study of the exosome's diagnostic and therapeutics market, it is estimated at USD 58.6 million in 2022 and is projected to reach USD 175.4 million by 2028, growing at a CAGR of 20.0% during the forecast period (2022-2028).

The global exosome diagnostic and therapeutics market development is conditional and influenced by regulatory approvals such as the EMA, the U.S. FDA, CE, and other regulatory authorities, following the impact of macro and industry factors.

FMI presents a comparative analysis of the market growth rates and development prospects in the global exosome diagnostic and therapeutics market. As per Future Market Insights' analysis, the exosome diagnostic and therapeutics market is expected to dip by 234 Basis Point Share (BPS) in the H1 2022 period in comparison to H1-2021.

Get Sample PDF Of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6379

Key Takeaways

  • The potential of exosomes as diagnostic biomarkers and in targeted drug delivery for oncology and neurodegenerative disorders are some of the key developments in this market.
  • The factors that impact industry growth positively include studies on exosome biogenesis pathways to inhibit disease-derived exosomes and using exosomes as delivery vehicles for therapeutics treatments.
  • The global exosomes diagnostic and therapeutics market is primarily driven by the rising prevalence of chronic diseases, such as neurodegenerative disorders, cancer, autoimmune diseases, etc., and the subsequent growth of production of drugs and drug delivery technologies with diagnostic assays for such chronic ailments.
  • The potential applications of biomarkers in cancer diagnostics and their role in the development of translational precision medicine are set to invoke the novel uses of exosomes in advanced therapeutics and diagnostic research.

Competitive Landscape

Thermo Fisher Scientific, NanoSomix, NX Pharmagen, Malvern Instruments, Capricor Therapeutics, Exosome Diagnostics, Exiqon A/S, System Biosciences, Exosome Sciences, Aegle Therapeutics, AMS Biotechnology, Miltenyi Biotec, Codiak BioSciences Inc., Lonza Group (HansaBioMed Life Sciences Ltd.) are some of the key companies profiled in the full version of the report.

Key players in the exosome's diagnostic and Therapeutics market utilize strategies involving management of their manufacturing operations through countries which offer lower manufacturing costs, development of novel diagnostic tests for diseases such as neurodegenerative disorders like Alzheimer's, and acquisition, development and monetization of mature clinical-stage breakthrough technologies.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6379

More Insights into the Exosome Diagnostic and Therapeutics Market

The U.S. dominates the North American region with a total market share of nearly 89.1% in 2021 and is projected to continue experiencing high growth throughout the forecast period.

Germany exhibited a Y-O-Y growth of nearly 26.4% in the Western Europe exosomes diagnostic and therapeutics market in 2021 and is expected to hold a market value share of 48.4% by the end of 2028.

The growth is associated with the rapid concentration of research activities in the applications of exosomes for accessing therapeutics effects of stem cells in the country. This growth was driven by the rising incidence of cancer in the country and the demand for advanced diagnostic assays.

China holds a 42.6% share in the APEJ market in 2021 and is projected to grow at a lucrative rate during the forecast period. The growth of the exosome diagnostic and therapeutics market in the country is attributed to the rise of clinically studied and observed applications of exosomes.

The overall growth of the exosomes diagnostic and therapeutics market is expected to rise at a significant pace due to rising cancer incidents all over the world, and demand for advanced diagnostic technology for the same.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-6379

Key Market Segments Covered in Exosomes diagnostic and therapeutic Market Research

By Product:

  • Instruments
  • Software
  • Reagents & Kits

By Application:

  • Diagnostics
  • Therapeutic

By End User:

  • Hospitals
  • Cancer Institutes
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Buy Now@ https://www.futuremarketinsights.com/checkout/6379

About the Healthcare Division at Future Market Insights

The Healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analysing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

More: https://www.prnewswire.com/news-releases/exosome-diagnostic-and-therapeutics-market-is-projected-to-expand-at-a-high-cagr-of-231-during-2017--2027-675814233.html

Have a Look at Related Research Reports:

Ophthalmic Diagnostic Equipment Market Overview - the global ophthalmic diagnostic equipment market is expected to increase from a valuation of US$ 3.0 Bn in 2022 to US$ 5.1 Bn by 2030

Dental Diagnostic and Surgical Equipment Market Share - The global dental diagnostic and surgical equipment market is projected to register a CAGR of 7.3% from 2022 to 2032.

Leukemia Therapeutics Treatment Market Size - the leukemia therapeutics treatment market is expected to record a CAGR of 7.1 per cent to reach a valuation of US$ 17 Bn by 2024, from a valuation of US$ 13 Bn in 2020

Lung Cancer Therapeutics Market Trends - The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Mn by 2026, exhibiting a CAGR of 13.4% in the forecast period

Peptide Therapeutics Market Forecast - The global Peptide Therapeutics Market is currently valued at US$ 34.4 Bn, and is expected to reach US$ 47 Bn by 2025, expanding at an impressive CAGR of 11% over the period of 2022 to 2025

Autoimmune Disease Therapeutics Market - The global market for autoimmune disease therapeutics is expected to have a robust growth during the forecast period (2016–2026).

Assisted Walking Devices Market: The global assisted walking devices market is augmented to hold the market revenue of USD 3.62 Billion in 2022 while it thrives on the CAGR of 6.4% between 2022 and 2032. The market is anticipated to reach USD 6.33 Billion by 2032.

Electronic Stethoscope Market: Global Electronic Stethoscope Market was valued at US$ 170.9 Mn in 2021 and the sales are expected to surpass US$ 259 Mn, increasing by 2.2x between 2022 and 2029.

Non-invasive Brain Stimulation System Market: The global non-invasive brain stimulation system market size is expected to reach US$ 2,429.3 Million by 2032. As per FMI Analysts, the global non-invasive brain stimulation system market is estimated to be valued at US$ 1,200.5 Million in 2022 and is projected to increase at a CAGR of 6.6% from 2022 to 2032.

Non-Hyaluronic Acid Dermal Filler Market: The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032. As per FMI Analysts, the global non-hyaluronic acid dermal filler market is estimated to be valued at US$ 392.7 Million in 2022 and is projected to increase at a CAGR of 2.6% from 2022 to 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com 
Website: https://www.futuremarketinsights.com  
Report: https://www.futuremarketinsights.com/reports/exosome-diagnostic-and-therapeutics-market

LinkedIn| Twitter| Blogs

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg

Modal title

Also from this source

Isoprene Rubber Latex Market is Projected to Expand at a CAGR of 8.1% between 2024 and 2034 | Future Market Insights, Inc.

Isoprene Rubber Latex Market is Projected to Expand at a CAGR of 8.1% between 2024 and 2034 | Future Market Insights, Inc.

The isoprene rubber latex industry is predicted to be valued at USD 922 million by 2024. The market valuation is estimated to be USD 2,005.3 million...

Growing Demand for Premium Distilled Agave-based Beverages to Propel Mezcal Market at a CAGR of 14.2% by 2034 | Future Market Insights, Inc.

Growing Demand for Premium Distilled Agave-based Beverages to Propel Mezcal Market at a CAGR of 14.2% by 2034 | Future Market Insights, Inc.

According to Future Market Insights (FMI), the global mezcal market demand is estimated to reach a valuation of USD 635 million by 2024. Over the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.